PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29524404-5	2018	Biochemical analysis showed that plasma ALT was increased by 35.8% in KO + CY group and decreased by 21.1% in WT + CY + Alda-1 group compared to WT + CY group (P < 0.05, respectively).	Cyclophosphamide	75-77	glutamic pyruvic transaminase, soluble	Mus musculus	40-43	
29524404-5	2018	Biochemical analysis showed that plasma ALT was increased by 35.8% in KO + CY group and decreased by 21.1% in WT + CY + Alda-1 group compared to WT + CY group (P < 0.05, respectively).	Cyclophosphamide	115-117	glutamic pyruvic transaminase, soluble	Mus musculus	40-43	
29524404-5	2018	Biochemical analysis showed that plasma ALT was increased by 35.8% in KO + CY group and decreased by 21.1% in WT + CY + Alda-1 group compared to WT + CY group (P < 0.05, respectively).	Cyclophosphamide	115-117	glutamic pyruvic transaminase, soluble	Mus musculus	40-43	
27802299-5	2016	The data of the present study showed that treatment of male mice with cyclophosphamide (2.5 mg/Kg BW) as repeated dose for 28 consecutive days was found to induce hepatotoxicity through the elevation in the activities of AST, ALT, and ALP.	Cyclophosphamide	70-86	glutamic pyruvic transaminase, soluble	Mus musculus	226-229	
24935324-5	2014	The ALT of patients reached the first peak of 144 +- 45.04 U/L, on day 7 after busulfan + cyclophosphamide (BU/CY) pretreatment, and reached the second peak of 220.5 +- 40.58 U/L on day 7 after transplantation.	Cyclophosphamide	90-106	glutamic pyruvic transaminase, soluble	Mus musculus	4-7